Teladoc Health Reports First Quarter 2022 Results

Go back to Teladoc Health Reports First Quarter 2022 Results

Teladoc (TDOC) Q1 Revenue Misses Consensus, Offers Guidance

April 27, 2022 4:10 PM EDT

Teladoc (NYSE: TDOC) reported Q1 EPS of ($41.58), may not compare to the analyst estimate of ($0.56). Revenue for the quarter came in at $565.4 million versus the consensus estimate of $568.8 million.

Net loss per share of $41.58, primarily driven by non-cash goodwill impairment charge of $6.6... More